DUCHENE TODD M 4

What Happened

• Todd M. Duchene, Core Scientific's Chief Legal and Administrative Officer, sold a total of 10,000 shares of CORZ in open-market transactions on June 8, 2026. The sales comprised 5,500 shares at a weighted-average price of $26.64 (proceeds $146,507) and 4,500 shares at a weighted-average price of $27.11 (proceeds $121,974), for aggregate proceeds of approximately $268,481. These were sales (not purchases), which are often routine disposition transactions.

Key Details

• Transaction dates: June 8, 2026 (reported on Form 4 filed June 10, 2026). Filing appears timely (within the usual 2-business-day requirement).
• Specifics:
  • 5,500 shares sold at weighted avg $26.64 (range reported: $25.96–$26.95) — proceeds $146,507. (Footnote F2)
  • 4,500 shares sold at weighted avg $27.11 (range reported: $26.97–$27.29) — proceeds $121,974. (Footnote F3)
  • Total sold: 10,000 shares for ~$268,481.
• Shares owned after the transaction: Not disclosed in the provided filing excerpt.
• Notable footnote: These sales were executed under a Rule 10b5-1 trading plan adopted by Mr. Duchene on December 5, 2025 (Footnote F1). The filing includes undertakings to provide per-price breakdowns on request.

Context

• 10b5-1 plans are pre-arranged trading arrangements that allow insiders to sell on a set schedule; transactions under such plans are generally considered planned and not necessarily a contemporaneous signal about the insider’s view of the company.